ZBIO · Zenas BioPharma Inc. Common Stock
View on chartInsiders & Stakes
| Enavate Sciences GP, LLC | ▲ Buy | Open Market | 3,761,359 Shares held | 9/16/2024 | View profile |
| Fairmount Funds Management LLC Director | ▲ Buy | Open Market | 2,359,025 Shares held | 3/31/2026 | View profile |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,917,895 Shares held | 10/9/2025 | View profile |
| Nunn Jason Raleigh Director | ▲ Buy | Open Market | 1,173,395 Shares held | 10/9/2025 | View profile |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | ▼ Sell | Other | 801,624 Shares held | 9/16/2024 | View profile |
| Hongbo Lu Director | ▲ Buy | Open Market | 422,968 Shares held | 3/31/2026 | View profile |
| Leon O. Moulder Jr. Chief Executive Officer | ▲ Buy | Open Market | 96,928 Shares held | 5/18/2026 | View profile |
| Xiao Ting Director | ▲ Buy | Open Market | 47,000 Shares held | 2/7/2025 | View profile |
| Allen Patricia L Director | ▲ Buy | Open Market | 19,860 Shares held | 2/13/2026 | View profile |
| Patrick G. Enright Director | ▲ Buy | Open Market | 11,990 Shares held | 10/9/2025 | View profile |
| Fox Jennifer A. See Remarks | ▲ Buy | Grant | 1,592 Shares held | 2/5/2026 | View profile |
| Farmer Joseph L See Remarks | ▲ Buy | Grant | 974 Shares held | 2/5/2026 | View profile |
Transaction History
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 60,000 | $1.0M | 5/18/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 35,000 | $617K | 4/29/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 25,000 | $451K | 4/28/2026 |
| Hongbo Lu | ▲ Buy | Open Market | 75,000 | $1.5M | 3/31/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 34,000 | $657K | 3/31/2026 |
| Hongbo Lu | ▲ Buy | Open Market | 3,768 | $70K | 3/31/2026 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 150,000 | $3.0M | 3/31/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 20,000 | $365K | 3/30/2026 |
| Allen Patricia L | ▲ Buy | Open Market | 4,160 | $110K | 2/13/2026 |
| Allen Patricia L | ▲ Buy | Open Market | 5,700 | $139K | 2/12/2026 |
| Allen Patricia L | ▲ Buy | Open Market | 5,000 | $133K | 2/12/2026 |
| Allen Patricia L | ▲ Buy | Open Market | 5,000 | $119K | 2/12/2026 |
| Hongbo Lu | ▲ Buy | Open Market | 25,985 | $585K | 2/11/2026 |
| Farmer Joseph L | ▲ Buy | Grant | 974 | $13K | 2/5/2026 |
| Fox Jennifer A. | ▲ Buy | Grant | 1,592 | $21K | 2/5/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 57,000 | $1.0M | 2/2/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 20,000 | $331K | 1/9/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 30,000 | $489K | 1/8/2026 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 50,000 | $819K | 1/7/2026 |
| Patrick G. Enright | ▲ Buy | Open Market | 11,990 | $250K | 10/9/2025 |
| Nunn Jason Raleigh | ▲ Buy | Open Market | 63,158 | $1.2M | 10/9/2025 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 63,158 | $1.2M | 10/9/2025 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 63,157 | $1.2M | 10/9/2025 |
| Patrick G. Enright | ▲ Buy | Open Market | 105,265 | $2.0M | 10/9/2025 |
| Hongbo Lu | ▲ Buy | Open Market | 263,160 | $5.0M | 10/7/2025 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 36,928 | $770K | 10/7/2025 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 316,219 | $6.0M | 10/7/2025 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 25,000 | $167K | 2/18/2025 |
| Xiao Ting | ▲ Buy | Open Market | 10,000 | $78K | 2/7/2025 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 45,000 | $449K | 12/4/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 25,000 | $269K | 12/3/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 2,500 | $36K | 11/19/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 7,500 | $113K | 11/18/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 2,367 | $42K | 9/20/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 2,633 | $50K | 9/20/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 5,000 | $89K | 9/19/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Open Market | 10,000 | $179K | 9/18/2024 |
| Patrick G. Enright | ▼ Sell | Other | 1,003,592 | — | 9/16/2024 |
| Patrick G. Enright | ▼ Sell | Other | 723,812 | — | 9/16/2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | ▼ Sell | Other | 420,271 | — | 9/16/2024 |
| Enavate Sciences GP, LLC | ▼ Sell | Other | 2,879,006 | — | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 501,796 | — | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,352,942 | $23.0M | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 441,176 | $7.5M | 9/16/2024 |
| Leon O. Moulder Jr. | ▼ Sell | Other | 372,017 | — | 9/16/2024 |
| Leon O. Moulder Jr. | ▼ Sell | Other | 48,254 | — | 9/16/2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | ▼ Sell | Other | 200,718 | — | 9/16/2024 |
| Enavate Sciences GP, LLC | ▲ Buy | Open Market | 882,353 | $15.0M | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 669,061 | — | 9/16/2024 |
| Leon O. Moulder Jr. | ▼ Sell | Other | 164,523 | — | 9/16/2024 |
| Leon O. Moulder Jr. | ▼ Sell | Other | 108,381 | — | 9/16/2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | ▼ Sell | Other | 180,635 | — | 9/16/2024 |
| Patrick G. Enright | ▼ Sell | Other | 334,530 | — | 9/16/2024 |
| Patrick G. Enright | ▲ Buy | Open Market | 440,000 | $7.5M | 9/16/2024 |
| Nunn Jason Raleigh | ▼ Sell | Other | 1,505,388 | — | 9/16/2024 |
| Nunn Jason Raleigh | ▲ Buy | Open Market | 441,176 | $7.5M | 9/16/2024 |
| Nunn Jason Raleigh | ▼ Sell | Other | 669,061 | — | 9/16/2024 |
| Nunn Jason Raleigh | ▲ Buy | Open Market | 441,176 | $7.5M | 9/16/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 41,130 | — | 9/16/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 252,890 | — | 9/16/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 709,794 | — | 9/16/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 301,077 | — | 9/16/2024 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 300,000 | $5.1M | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 1,505,388 | — | 9/16/2024 |
| SR ONE CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 441,176 | $7.5M | 9/16/2024 |
| Hongbo Lu | ▲ Buy | Open Market | 58,823 | $1000K | 9/13/2024 |
| Hongbo Lu | ▲ Buy | Open Market | 58,823 | $1000K | 9/13/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
ZBIO releases Phase 3 Obexelimab data, plans MS trial presentations
The company released new Phase 3 results for its Obexelimab program in IgG4‑related disease, which were presented at a recent international symposium. The data release coincided with a 5.1% share decline. Zenas also announced upcoming virtual presentations of Orelabrutinib data for multiple sclerosis at MSToronto2026 and a broader R&D webcast. Analyst HC Wainwright kept its $44 price target, reinforcing its view on the stock.
ZBIO releases Phase 3 Obexelimab data, plans MS trial presentations. The company released new Phase 3 results for its Obexelimab program in IgG4‑related disease, which were presented at a recent international symposium. The data release coincided with a 5.1% share decline. Zenas also announced upcoming virtual presentations of Orelabrutinib data for multiple sclerosis at MSToronto2026 and a broader R&D webcast. Analyst HC Wainwright kept its $44 price target, reinforcing its view on the stock.